Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Avencell Europe Gmbh

Clinical trials sponsored by Avencell Europe Gmbh, explained in plain language.

New 'Living Drug' trial targets Tough-to-Treat blood cancers

Disease control Terminated

This early-stage trial tested a new type of personalized cell therapy for adults with acute myeloid leukemia (AML) that has come back or hasn't responded to other treatments. Doctors modified patients' own immune cells (T-cells) to target a protein called CD123 found on cancer ce…

Phase: PHASE1 • Sponsor: AvenCell Europe GmbH • Aim: Disease control

Last updated Mar 11, 2026 14:54 UTC